Prevalence of Medication-Dietary Supplement Combined Use and Associated Factors.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
15 Oct 2019
Historique:
received: 27 08 2019
revised: 03 10 2019
accepted: 05 10 2019
entrez: 18 10 2019
pubmed: 18 10 2019
medline: 26 3 2020
Statut: epublish

Résumé

The use of medication has increased in recent years in the US while the use of dietary supplements has remained stable but high. Interactions between these two kinds of products may have important consequences, especially in the case of widely used medications such as antihypertensives and antibiotics. The aim of this paper is to estimate the prevalence of potentially serious drug-dietary supplement interactions among tetracyclines, thiazides, and angiotensin II receptor blocker users by means of the NHANES 2013-2014 dataset. Data from 2013-2014 NHANES were obtained. Potential interactions analysed were tetracyclines with calcium, magnesium, and zinc, thiazides with vitamin D, and angiotensin II receptors blockers with potassium. Prevalence was calculated for each potential interaction. Logistic regression was used to assess associated factors. 864 prescriptions issued to 820 patients were analysed. Overall prevalence of potential interaction was 49%. Older age and higher educational level were strongly associated with being at risk of a potential interaction. Factors such as age, race, civil status, citizenship, country of birth, BMI, and physical activity did not show notable associations. Healthcare professionals should be aware of other medical products when they prescribe or dispense a medication or a dietary supplement, especially to the older population and people with a higher educational level.

Identifiants

pubmed: 31618867
pii: nu11102466
doi: 10.3390/nu11102466
pmc: PMC6835757
pii:
doi:

Substances chimiques

Angiotensin Receptor Antagonists 0
Anti-Bacterial Agents 0
Antihypertensive Agents 0
Sodium Chloride Symporter Inhibitors 0
Tetracyclines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

JAMA. 2016 Dec 13;316(22):2385-2401
pubmed: 27959996
PLoS One. 2019 Mar 22;14(3):e0214240
pubmed: 30901377
Int J Cardiol. 2017 Aug 1;240:409-413
pubmed: 28487151
JAMA. 2008 Dec 24;300(24):2867-78
pubmed: 19109115
J Am Coll Nutr. 2000 Oct;19(5):613-21
pubmed: 11022875
JAMA Intern Med. 2016 Apr;176(4):473-82
pubmed: 26998708
J Am Geriatr Soc. 2009 Jul;57(7):1197-205
pubmed: 19515113
Drug Saf. 2007;30(1):71-80
pubmed: 17194172
Sleep. 2019 Apr 1;42(4):null
pubmed: 30657987
JAMA. 2015 Nov 3;314(17):1818-31
pubmed: 26529160
Cureus. 2018 Jun 5;10(6):e2741
pubmed: 30087817
Nutrients. 2019 May 02;11(5):null
pubmed: 31052522
Oman Med J. 2011 Mar;26(2):77-83
pubmed: 22043389
J Health Commun. 2013;18 Suppl 1:172-84
pubmed: 24093354
JAMA. 2016 Oct 11;316(14):1464-1474
pubmed: 27727382
Clin Geriatr Med. 2014 Aug;30(3):629-54
pubmed: 25037298

Auteurs

Ignacio Aznar-Lou (I)

Teaching, Research & Innovation Unit, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Parc Sanitari Sant Joan de Déu, 08830 Sant Boi de Llobregat (Barcelona), Spain. i.aznar@pssjd.org.
Centro de Investigación Biomédica en Red en Epidemiología y Salud Pública, CIBERESP, 28029 Madrid, Spain. i.aznar@pssjd.org.

Cristina Carbonell-Duacastella (C)

Teaching, Research & Innovation Unit, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Parc Sanitari Sant Joan de Déu, 08830 Sant Boi de Llobregat (Barcelona), Spain. c.carbonell@pssjd.org.

Ana Rodriguez (A)

Spanish Society of Community and Family Pharmacy (SEFAC), 28045 Madrid, Spain. ana.rodriguez@sefac.org.

Inés Mera (I)

Spanish Society of Community and Family Pharmacy (SEFAC), 28045 Madrid, Spain. ines.mera@hotmail.es.

Maria Rubio-Valera (M)

Teaching, Research & Innovation Unit, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Parc Sanitari Sant Joan de Déu, 08830 Sant Boi de Llobregat (Barcelona), Spain. mrubio@pssjd.org.
Centro de Investigación Biomédica en Red en Epidemiología y Salud Pública, CIBERESP, 28029 Madrid, Spain. mrubio@pssjd.org.
School of Pharmacy, University of Barcelona, 08028 Barcelona, Spain. mrubio@pssjd.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH